Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)
Clinical trial NCT01927718 · TERMINATED
Trial details
- NCT number
- NCT01927718
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.